Literature DB >> 11589347

Sarcoidosis severity and socioeconomic status.

D L Rabin1, M S Richardson, S R Stein, H Yeager.   

Abstract

Several chronic diseases are more severe in persons who are Black, of low socioeconomic status (SES), and underinsured. The authors ask if this is true for sarcoidosis. Associations among sarcoidosis disease severity, SES, insurance coverage, and functional limitations were analysed. Back and White sarcoidosis patients (n=110) of a municipal and university hospital sarcoidosis registry were interviewed by telephone. Data on disease severity were abstracted from patient charts. Most patients reported good or excellent health by demographic characteristics. Low SES and no or public insurance were associated with worse health status and more severe dyspnoea. More advanced radiographic stage was associated with lower income, and forced vital capacity impairment with less education. Physical and social activity limitations due to physical and emotional disability were related to no or public insurance and lower income, but not education. Sarcoidosis severity is associated with socioeconomic status and insurance indicators; no or public insurance and low income are associated with functional limitations. Sarcoidosis-associated limitations are substantial, emphasizing the social significance of sarcoidosis. Lack of private insurance may inhibit the use of medical care, contributing to disease severity and impairment.

Entities:  

Mesh:

Year:  2001        PMID: 11589347     DOI: 10.1183/09031936.01.00056201

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Quality of life in sarcoidosis: comparing the impact of ocular and non-ocular involvement of the disease.

Authors:  Leorey N Saligan; Grace Levy-Clarke; Tongtong Wu; Lisa J Faia; Keith Wroblewski; Steven Yeh; Robert B Nussenblatt; H Nida Sen
Journal:  Ophthalmic Epidemiol       Date:  2010-08       Impact factor: 1.648

2.  Clinical manifestations of sarcoidosis among inner-city African-American dwellers.

Authors:  Gökhan M Mutlu; Israel Rubinstein
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

Review 3.  Disease Burden and Variability in Sarcoidosis.

Authors:  Alicia K Gerke; Marc A Judson; Yvette C Cozier; Daniel A Culver; Laura L Koth
Journal:  Ann Am Thorac Soc       Date:  2017-12

Review 4.  How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants.

Authors:  Manuel Ramos-Casals; Belchin Kostov; Pilar Brito-Zerón; Antoni Sisó-Almirall; Robert P Baughman
Journal:  Lung       Date:  2019-06-12       Impact factor: 2.584

5.  Area-level socioeconomic disadvantage and severe pulmonary tuberculosis: U.S., 2000-2008.

Authors:  Eyal Oren; Masahiro Narita; Charles Nolan; Jonathan Mayer
Journal:  Public Health Rep       Date:  2013 Mar-Apr       Impact factor: 2.792

6.  CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis.

Authors:  Nicholas K Arger; Melissa E Ho; Isabel E Allen; Bryan S Benn; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-11-20       Impact factor: 3.415

7.  Socioeconomic status affects pulmonary hypertension disease severity at time of first evaluation.

Authors:  Arunabh Talwar; Sonu Sahni; Ankoor Talwar; Nina Kohn; James R Klinger
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

8.  Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis.

Authors:  Logan J Harper; Alicia K Gerke; Xiao-Feng Wang; Manuel L Ribeiro Neto; Robert P Baughman; Kelli Beyer; Marjolein Drent; Marc A Judson; Lisa A Maier; Leslie Serchuck; Noopur Singh; Daniel A Culver
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

9.  Comorbid illnesses and chest radiographic severity in African-American sarcoidosis patients.

Authors:  Gloria E Westney; Sadia Habib; Alexander Quarshie
Journal:  Lung       Date:  2007-03-24       Impact factor: 3.777

10.  Proceedings of the 2015 AASOG conference: Reducing disparities in sarcoidosis through personalized care and increased detection.

Authors:  Hamzeh Nabeel; A Judson Marc; A Maier Lisa
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.